Leadership Transition at Roche Diagnostics Canada

LAVAL, QC - June 30, 2026 - Roche Canada today announces that Matheus Vieira, currently President & General Manager of Roche Diagnostics Canada, will assume a new global leadership position as Global Commercialisation Strategy Leader, Obesity and  Metabolism at Roche Headquarters in Basel, Switzerland, effective July 1, 2026.

Over the past three years, Matheus has demonstrated a deep passion for bringing innovation to life, tirelessly advocating for healthcare solutions to reach all patients, regardless of where they live. He leaves a legacy of immense impact on patients: 1 in 4 benefits from our diagnostics innovations in diagnostics. Under his leadership, the affiliate fostered a high-engagement culture, achieved record growth, and collaborated closely with healthcare stakeholders to accelerate the adoption of high-medical-value solutions for as many Canadians as possible.

“Accelerating innovation for patients in Canada has been a privilege, but my greatest inspiration has been the Canadian people—whose empathy, resilience, and spirit of collaboration made our massive patient impact possible. We touched millions of lives because we worked as one. As I leave, I am proud to carry a piece of Canada’s heart with me.” - Matheus Vieira -

While the search for a permanent successor is underway, Michele D’Elia, currently Executive Director, Medical, Access and Policy will also serve as Interim General Manager to ensure a seamless transition. 

Roche Canada remains steadfast in its long-term commitment to ensuring that innovative diagnostic solutions reach the patients who need them most, while also fostering a vibrant and evolving healthcare sector.